Nazim Arain Shares The New Standard: Anticoagulation in Cirrhosis
Nazim Arain, Consultant Internal Medicine and Gastroenterologist at Almana Group of Hospitals, shared on LinkedIn:
”Anticoagulation in Cirrhosis: The New Standard
Patients with cirrhosis face an increased risk of thrombotic events like AF and VTE.
It’s now accepted that their coagulation is “rebalanced,” making anticoagulation the standard of care to reduce stroke/thrombosis risk!
The primary bleeding risk is linked to portal hypertension, NOT general clotting deficiency.
Direct Oral Anticoagulants (DOACs) can be considered for Child-Pugh A and Bpatients.
LMWH often preferred in Child-Pug-C.
Read the full review.”
Read the full review article here.
Article: Anticoagulation in cirrhosis
Authors: Lara Roberts
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda
-
Aug 11, 2026, 05:38Rami Unterman: A Simple New Biomarker for Fibrotic ILDs
-
Aug 11, 2026, 04:10Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show
-
Aug 11, 2026, 02:54Tareq Abadl: The Ultimate Guide to Clinically Significant Antibodies
-
Aug 10, 2026, 17:35Chokri Ben Lamine: Balancing Holistic Care and Precision in Hematology
-
Aug 10, 2026, 17:14Anna Stanizzi: Patient Blood Management as a New Model of Personalized Care
-
Aug 10, 2026, 17:12Odong Christopher: New Research on Ischemic Stroke Prediction in Uganda
-
Aug 10, 2026, 16:58Jeff Szer AM: Advancing the Management of Paroxysmal Nocturnal Hemoglobinuria